Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Proellex pharmacokinetic bridging study II

Trial Profile

Proellex pharmacokinetic bridging study II

Phase of Trial: Phase I

Latest Information Update: 20 Jun 2008

At a glance

  • Drugs Telapristone (Primary)
  • Indications Endometriosis; Uterine leiomyoma
  • Focus Pharmacokinetics
  • Sponsors Repros Therapeutics
  • Most Recent Events

    • 28 Mar 2008 The expected completion date for this trial is now 1 Apr 2008, as reported by clinicaltrials.gov.
    • 28 Mar 2008 Status change from recruiting to in progress, as reported by clinicaltrials.gov.
    • 26 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top